Molecular Therapy AdvancesBioengineeringPeer-reviewed journal article
Development of the EASY-HSV (Efficient And Simple high-Yield Herpes Simplex virus Vector) system based on HSV-1 genome-maintaining HEK293 cells
Fumio MaedaiD, Moeka NobeiD, Kenichiro ImaiiD, Shungo AdachiiD, Tohru NatsumeiD
Abstract
Herpes simplex virus (HSV) amplicon vector is a promising molecular tool with a large transgene capacity of 150 kb. However, the conventional vector production method is labor-intensive and expensive, limiting its application. Here, we generated HEK293 cells harboring the HSV genome (293/HSV) and developed an EASY-HSV (Efficient And Simple high-Yield Herpes Simplex virus Vector) system in which 293/HSV cells are transfected with only two plasmids.
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- top 39%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Herpes Simplex Virus-1 targets the 2-3cGAMP importer SLC19A1 as an antiviral countermeasure.
Z. K. Szemere, E. A. Murphy·VirologyPeer-reviewed·Feb 1, 2025
- Cell-to-cell transmission of HSV1 in human keratinocytes in the absence of the major entry receptor, nectin1
J. Kite, T. Russell, … G. Elliott·bioRxiv·May 13, 2021
- The producer cell type of HSV-1 alters the proteomic contents and infectious capacity of virions
Gary P. Dunn, Luke F. Domanico, Matthew P. Taylor·Journal of VirologyPeer-reviewed·Aug 19, 2025
- Ultrasensitive capture of human herpes simplex virus genomes directly from clinical samples reveals extraordinarily limited evolution in cell culture
Alexander L. Greninger, Pavitra Roychoudhury, … Keith R. Jerome·mSpherePeer-reviewed·Jun 12, 2018
- Intracorneal delivery of HSV-targeting CRISPR/Cas9 mRNA prevents herpetic stromal keratitis
- The Herpes Simplex Virus Tegument Protein pUL21 is Required for Viral Genome Retention Within Capsids
E. C. M. Thomas, M. Bossert, B. W. Banfield·bioRxiv·Jul 14, 2022